Common use of Product Specifications; Testing Clause in Contracts

Product Specifications; Testing. (a) Certain of the Packaging Specifications are appended to this Agreement as Appendix 2. The Parties acknowledge that those Packaging Specifications set forth in Appendix 2 which are specific to the Secondary Production under this Agreement, namely those procedures 211.MedImmune.1 through 211.MedImmune.12 and V0008 and V0014, may need to be refined and modified as the Parties gain experience with Secondary Production, testing and use of Product. Accordingly, the Parties agree to negotiate in good faith to modify those MedImmune specific procedures from time to time as the Parties’ experience with Secondary Production, testing and use of Product warrant; and Cardinal Health further agrees that it will facilitate changes to Appendix 2 that are necessary or appropriate in light of FDA or other regulatory requirements. The Parties agree to allocate on an equitable basis any special costs of developing and implementing revised procedures. (b) Product supplied hereunder will conform to the Packaging Specifications, and such conformance will be verified in accordance with the testing standards and procedures specified therein. Cardinal Health will forward a sample of each batch of Product to MedImmune for testing and will supply MedImmune with a certificate of release (“Certificate of Release”) confirming that such Product produced meets the Packaging Specifications. (c) The Parties agree to work together in good faith to develop more efficient packaging and testing procedures.

Product Specifications; Testing. (a) Certain of the Packaging Specifications are appended to this Agreement as Appendix 2. The Parties acknowledge that those Packaging Specifications set forth in Appendix 2 which are specific to the Secondary Production under this Agreement, namely those procedures 211.MedImmune.1 through 211.MedImmune.12 and V0008 and V0014, may need to be refined and modified as the Parties gain experience with Secondary Production, testing and use of Product. Accordingly, the Parties agree to negotiate in good faith to modify those MedImmune specific procedures from time to time as the Parties’ ' experience with Secondary Production, testing and use of Product warrant; and Cardinal Health further agrees that it will facilitate changes to Appendix 2 that are necessary or appropriate in light of FDA or other regulatory requirements. The Parties agree to allocate on an equitable basis any special costs of developing and implementing revised procedures. (b) Product supplied hereunder will conform to the Packaging Specifications, and such conformance will be verified in accordance with the testing standards and procedures specified therein. Cardinal Health will forward a sample of each batch of Product to MedImmune for testing and will supply MedImmune with a certificate of release (“"Certificate of Release”") confirming that such Product produced meets the Packaging Specifications. (c) The Parties agree to work together in good faith to develop more efficient packaging and testing procedures.